
Tharimmune Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Tharimmune Inc
Access all reports
Tharimmune Inc. is a biopharmaceutical company focused on the development of immune-modulating therapies for inflammatory diseases and cancer. The company specializes in small molecule and biologic drug candidates designed to regulate immune responses and target disease pathways. Tharimmune conducts clinical research and drug development to address unmet medical needs in autoimmune disorders, oncology, and fibrosis-related conditions. The company is headquartered in Westlake Village, California, and its shares are listed on the NASDAQ.
Key slides for Tharimmune Inc


Corporate Presentation
Tharimmune Inc


Corporate Presentation
Tharimmune Inc
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
THAR
Country
🇺🇸 United States